Engineered cells take drugs deep into the brain and nowhere elseEngineered T cells can deliver drugs directly to brain tumors by crossing the blood-brain barrier.
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas - NatureCAR T-cell therapy may offer new hope in treating H3K27M-mutated diffuse midline gliomas with targeted GD2-CAR T-cells.
'A brain tumour the size of a tennis ball came out my eyebrow'A pioneering eyebrow surgery for large brain tumours in Scotland reduces recovery time and complications, revolutionizing traditional neurosurgical methods.
Molecular Profiling May Improve Meningioma Decisionmaking - News CenterMolecular profiling of meningiomas can predict treatment response and improve patient outcomes.
Investigators Discover New Therapeutic Target for Pediatric Brain Cancers - News CenterTargeting TIM3 protein may enhance survival in pediatric brain cancer treatments, specifically low-grade astrocytoma, presenting a potential new therapeutic option.
New Drug Shows Promise for Treating Rare Brain Tumors - News CenterAn experimental drug, dordaviprone, shows promise in treating H3 K27M-mutant diffuse midline gliomas.The study revealed a 30% positive response rate to the drug in patients with this rare brain tumor subtype.
This kids' brain cancer is incurable - but immune therapy holds promiseCAR-T therapy shows promise in treating deadly brain tumors in children.
New Drug Shows Promise for Treating Rare Brain Tumors - News CenterAn experimental drug, dordaviprone, shows promise in treating H3 K27M-mutant diffuse midline gliomas.The study revealed a 30% positive response rate to the drug in patients with this rare brain tumor subtype.
This kids' brain cancer is incurable - but immune therapy holds promiseCAR-T therapy shows promise in treating deadly brain tumors in children.
Plaschke: With the help of Dodgers history, team historian Mark Langill battles brain cancerThe power of love for a team can be a strong anchor during health battles.